Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 60,396 | 44,853 | 25,006 | 28,884 | 22,838 |
| Cost of Goods | 17,188 | 5,225 | 4,460 | 4,557 | 4,117 |
| Gross Profit | 43,208 | 39,628 | 20,546 | 24,327 | 18,721 |
| Operating Expenses | 42,578 | 49,796 | 38,315 | 38,131 | 35,627 |
| Operating Income | 818 | -9,943 | -17,309 | -13,247 | -16,789 |
| Interest Expense | 4,110 | 4,079 | 4,109 | 3,720 | 2,335 |
| Other Income | 5,116 | 16,749 | 16,394 | 13,457 | 9,857 |
| Pre-tax Income | 1,824 | 2,727 | -5,024 | -3,510 | -9,267 |
| Income Tax | 138 | 157 | 192 | 354 | 26 |
| Net Income Continuous | 1,686 | 2,570 | -5,216 | -3,864 | -9,293 |
| Net Income | $1,686 | $2,570 | $-5,216 | $-3,864 | $-9,293 |
| EPS Basic Total Ops | 0.02 | 0.03 | -0.05 | -0.04 | -0.10 |
| EPS Basic Continuous Ops | 0.02 | 0.03 | -0.05 | -0.04 | -0.10 |
| EPS Diluted Total Ops | 0.02 | 0.03 | -0.05 | -0.04 | -0.10 |
| EPS Diluted Continuous Ops | 0.02 | 0.03 | -0.05 | -0.04 | -0.10 |
| EBITDA(a) | $1,849 | $-9,675 | $-17,357 | $-13,109 | $-15,946 |